and two cyclosporin A toxicity). Eight patients with a recurrence of DDD have progressed to ESRD at an Background. Dense deposit disease (DDD) is an uncommon cause of end-stage renal disease ( ESRD). average of 14 months (range 0.2-38 months) after transplantation. The recurrence was the sole cause of As a consequence, information on the outcome of renal transplantation in patients with DDD comes graft loss in the three patients with crescents. The patients in whom the C3 deposits were confined to the from series with a limited number of patients. Methods. We present the histological and clinical data mesangium appeared to have a better prognosis.
were found: globular depositions only in the mesangium; mesangial accumulation with linear deposits in Dense deposit disease (DDD), also known as type II the capillary wall; and prominent linear presence in membranoproliferative glomerulonephritis, is an the capillary wall with only a few mesangial granules.
uncommon form of glomerulonephritis. The disease The findings by electron microscopy matched the runs a progressive course toward end-stage renal disimmunofluorescence results. The linear C3 accumulaease ( ESRD) in the majority of patients, often necessittion in the capillary wall was visible ultrastructurally ating renal transplantation. It is known from several as electron-dense ribbon-like transformation of the small series and case reports that a histological recurglomerular basement membrane. Mesangial C3 rence frequently is seen after transplantation, although deposits were seen ultrastructurally as local electronthe reported recurrence rate varies from 18 to 100% dense deposits in the mesangium. Four patients showed [1, 2] . Despite this high rate of histological recurrence, a pronounced glomerular influx of neutrophils, accomthe clinical implications of such a recurrence may be panied by crescents in three patients. In these three of limited importance. In the previously published latter patients, the recurrence of DDD was the only series, the recurrence of DDD was held responsible for histological lesion. In the other patients, the recurrence graft loss in 16% of patients with DDD [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . was merely a coincidence, the biopsy demonstrating
We have analysed the data and revised all renal an additional histological lesion (three chronic vascular transplant biopsies of the patients with DDD who rejection, two acute rejection, one ischaemic necrosis have received a renal transplant in our centre. We specifically have addressed the incidence of recurrence Correspondence and offprint requests to: M. B. Andresdottir, MD, and the impact of recurrence on graft outcome. Our Department of Medicine, Division of Nephrology, University data suggest that recurrent DDD may have different
Statistical analyses

Subjects and methods
Unless otherwise noted, values are given as mean±SD. The subjects of the present study were all adult patients (age >14 years) with DDD, who had received a kidney transplant in our centre in the period between August 1983 and October Results 1994. The diagnosis of the original disease was confirmed by revision of the original renal biopsies. In the study period, we have used different regimens of immunosuppressive Out of 727 adult patients who received a first renal therapy, as described before [16 ] . In brief, from 1983 to transplant in our centre in the period from 1983 to 1985, patients were treated in a randomized study with either 1994, 178 patients had a diagnosis of primary glomcyclosporin (CsA; starting with 17.5 mg/kg/day and tapering erulonephritis. In 63% of these patients, a histological to 5 mg/kg/day at 3 months) and prednisone for the first 3 diagnosis was available. We have identified 13 patients months followed by conversion to azathioprine and prednis-with DDD in their native kidneys. The clinical characone, or azathioprine and prednisone for the whole period. teristics of these patients are given in Table 1. In two   From 1985 to 1989, all patients received CsA and prednisone patients, there was evidence of lipodystrophy (nos 3 during the first 3 months and azathioprine and prednisone and 13). During follow-up, one or more renal biopsies thereafter. In the period from 1989 to 1992, patients were were performed in 11 patients. Histological abnormalittreated with CsA (starting with 12 mg/kg/day and tapering to 4 mg/kg/day at 3 months) and prednisone for the first 3 ies suggesting a recurrence of DDD were found in the months and thereafter were randomized for continued treat-biopsies of all 11 patients, at a median of 2.9 months ment with either azathioprine and prednisone or CsA mono-after transplantation (range 0.4-13.8 months). The therapy. Since 1992, the combination of CsA and prednisone indication for the graft biopsy was in all cases a raised has been the cornerstone of our immunosuppressive therapy. serum creatinine. In five patients, renal dysfunction All patients were followed-up after transplantation at was accompanied by proteinuria and in one by regular intervals (weekly for the first 4 months, every 2-4 haematuria.
weeks thereafter and from 1 year on at least every 3 months). At each visit, blood pressure, serum creatinine and urinary protein were recorded. Throughout the study period, the Histological findings criteria for performing a renal allograft biopsy were proteinuria (>2 g/24 h) or a decrease in renal function. For the purpose of this study, the medical records of all patients Table 2 shows the details of all renal graft biopsies with DDD were analysed. The following data were docu-(n=18) performed in our 11 patients (six patients with mented for each patient: gender, age at diagnosis of the two or more biopsies). A recurrence was seen as early original disease (defined as the time of the renal biopsy), as 12 days after transplantation (patient no. 1), and time from diagnosis to ESRD, age at transplantation, the the recurrence was already detectable in the first availdonor source and gender, immunosuppressive therapy post-able biopsy in all but one patient. In this latter patient transplant, the occurrence of rejection episodes and comple-(no. 2), the recurrence did not become evident until ment levels before and after transplantation, when available.
the third biopsy at 14 months post-transplant. By light Furthermore, proteinuria and serum creatinine were followed microscopy, glomerular abnormalities characteristic of yearly, and end points were noted. All available biopsies glomerulonephritis were found in five patients, confrom the post-transplant period were revised. A diagnosis of DDD in the original kidney biopsy was based on the findings sisting of prominent glomerular influx of neutrophils of light microscopy [change of the normal staining qualities in biopsies of four patients ( Figure 1A ), in three of glomerular basement membrane (GBM ) into a ribbon-patients accompanied by crescents ( Figure 1B ) or like refractile appearance, and an increase in mesangial mesangial cell proliferation and matrix accumulation matrix and cells], electron microscopy (electron-dense ribbon-(nos 1 and 4). However, the characteristic GBM like transformation of the GBM and electron-dense mesang-abnormalities, suggestive of DDD, such as eosinial deposits) and immunofluorescence (presence of globular coloured, ribbon-like transformation of the GBM in deposits of C3 in the mesangium and linear or homogenous silver methenamine-stained sections, were only seen in deposits of C3 of the glomerular capillary wall (GCW )). All one patient (no. 4). In all cases, electron microscopy transplant biopsies were reviewed and the light microscopy, and immunofluorescence studies were essential in immunofluorescence and electron microscopy findings docuestablishing a diagnosis of recurrent DDD. There were mented. Rejection was scored according to the Banff classification [17] .
three different patterns of glomerular C3 depositions For light microscopy, a part of the kidney biopsy was by immunofluorescence as seen by Figure 2A -C: in fixed in Bouin's solution, dehydrated and embedded in patients 1-3, the recurrence manifested itself solely paraplast (Amstelstad, Amsterdam, The Netherlands). with globular depositions of C3 in the mesangium in Sections were stained with haematoxylin-eosin, periodic the absence of deposits in the GCW. In all other acid-Schiff and silver methenamine. For immunofluores-patients, C3 deposits could be demonstrated in the cence, kidney fragments were snap-frozen in liquid nitrogen, glomerular capillary loop in a linear or homogenous and 2 mm cryostat sections were incubated with fluorescein-pattern with heavy mesangial accumulation ( In all patients with C3 staining in the peripheral staining intensity was recorded semi-quantitatively on a scale capillary wall, electron microscopy also showed the from 0 to 3. For electron microscopy, a small piece of the biopsy was processed as described earlier [18] . typical electron-dense alterations of the GBM. In con-trast, in the patients whose recurrence was characterized by the sole presence of globular deposits in the mesangium by immunofluorescence, the GBM abnormalities were absent by electron microscopy. The original biopsy of these three patients, however, revealed by electron microscopy the characteristic electrondense transformation of the GBM with dense mesangial deposits (data not shown). The recurrence of DDD was the only histological finding in the biopsy of three patients (nos 9-11), all these patients having epithelial crescents. In the biopsies from all the other patients with recurrence, there was an additional histological lesion [chronic vascular rejection (n=3), acute rejection (n=2), ischaemic necrosis (n=1) and CsA toxicity (n=2)], which could explain the increased creatinine or the proteinuria.
Clinical outcome
Thus far, eight patients with a recurrence of DDD have lost their grafts, at an average of 14 months (range 0.2-38 months) after transplantation. The recurrence was considered to be solely responsible for the deterioration of graft function and eventual graft loss in the three patients whose biopsies demonstrated crescents. In four patients, graft loss was attributed chiefly to the rejection process, whereas one patient died at 39 months after transplantation, with a failing graft due to chronic vascular rejection. Only three patients with recurrence of DDD currently have a stable graft function at 28, 29 and 52 months, respectively. Two of these patients only had mesangial deposits, without involvement of the peripheral capillary wall. When we compared patients with a clinically significant recurrence and those without, we found that all the patients with a clinical recurrence had epithelial crescents, whereas the others did not. We were unable to identify any other factor that would allow the prediction of a clinical recurrence, such as gender, age at transplantation, time to development of ESRD in native kidneys or donor source. The presence of crescents in the native kidneys (nos 3, 4 and 9) also did not predict the development of crescentic glomerulonephritis in the graft. Furthermore, the use of CsA did not prevent the histological or clinical recurrence of DDD. We had information on C3 levels of eight patients before and of seven patients after transplantation. In all eight patients, the C3 was low during the course of the disease in their own kidneys. After transplantation (before or around the time of the transplant biopsy), the C3 was still low in four patients but was normalized in three patients. Of the three patients with only C3 deposition in the mesangium, two had a normal C3 at the time of the biopsy (nos 1 and 2). One patient with evident DDD with crescents (no. 10) also had a normal C3 at the time of biopsy.
One of the patients (no. 9) with graft failure caused by the recurrence has received a second graft. This graft has a satisfactory function 7 years after transplantation, without significant proteinuria. aThe most likely cause of the graft failure is given in parentheses. P, prednisone; CsA, cyclosporin A; Aza, azathioprine; P/CsA-c, conversion after first 3 months to prednisone and azathioprine; NA, not applicable; CVR, chronic vascular rejection. observed in three patients bright, globular deposits of
Discussion
C3 in the mesangium in the absence of any abnormality of the GCW in immunofluorescence or electron microStudies in which transplant biopsies were performed scopy, while the original biopsy showed the characterroutinely have demonstrated that the recurrence of istic electron-dense changes of the GBM by electron DDD can be clinically silent for many years [3] . microscopy. It is questionable whether the mere presTherefore, if the post-transplant period is not complicence of such mesangial deposits can be regarded as ated by an acute or chronic rejection episode, and evidence of a recurrent DDD, since usually the presence biopsies are not routinely taken, as is the case in our of dense osmiophilic deposits in the GBM, basal lamina centre, a histological recurrence can be missed. In our of Bowman's capsule, TBMs and mesangial regions is study, histological evidence of a recurrence of DDD considered to be the hallmark of the disease [19] . was found in 11 out of 13 patients, giving a minimum There are, however, several arguments that support estimate of the recurrence rate of 85%. If we only our contention that the histological expression of DDD include patients with a biopsy, the recurrence rate is may be more variable. Although we do not have as high as 100% (11/11). Our results are in close follow-up biopsies in our patients, we have found two agreement with the data from most previous series patients in the literature who show a progression from ( Table 3) . The difference in recurrence rate between mesangial deposits only to the characteristic GCW series apparently varies from 18 to 100%, but if we involvement [5, 10] . Furthermore, an identical include in the analysis only those patients with a immunofluorescence picture of C3 in a granular pattern representative biopsy (i.e. including electron microin the mesangium, in the absence of clear GBM scopy and immunofluorescence), the recurrence rate staining, is shown in Heptinstall's Pathology of the averages 98% ( Table 3) . A recurrence of the DDD can Kidney [19] . This picture comes from a kidney biopsy be noted as early as 12 days after transplantation. In of a patient with DDD. Finally, even if one cannot our centre, nine recurrences were diagnosed within 9 exclude that the deposits in these three patients are of months after transplantation. It is obvious, however, donor origin, this seems highly unlikely if one considers that these data are totally dependent on the timing of the fact that this same pattern is observed in all three the biopsy, since most recurrences are found by chance.
patients. We hypothesize that the mesangial deposition Our study demonstrates that the histological characteristics of a recurrent DDD can be quite variable. We of C3 could be an early sign of a recurrence. This theory would be supported if the mesangial deposition alone was seen in the early biopsies or, more convincingly, if in sequential biopsies mesangial deposition was seen first, followed by deposition in the peripheral capillary wall. Two of the three patients (nos 1 and 2) had early biopsies (0.4 and 0.8 months posttransplant), and the third one (no. 3) had a biopsy showing the recurrence at 13.8 months; however, two earlier biopsies did not show a recurrence, and thus this biopsy was the first sign of a recurrence. Alternatively, it is possible that a recurrence of DDD can manifest itself in different ways on histology. These different patterns may even be relevant for the subsequent clinical course. In our study, the patients with only mesangial deposits experienced a milder clinical course, with two out of three still having a functioning graft.
It is well known that an accumulation of neutrophils can be seen in glomeruli of patients with DDD [20] . The influx of neutrophils has been attributed to the presence of GCW deposits. We also observed an influx of neutrophils in the glomeruli in the biopsies of some patients. However, the presence of these neutrophils was not related to the presence of deposits in the GCW. Neutrophils were seen predominantly in the biopsies from the patients with crescentic lesions.
The pathogenesis of DDD is not known, nor is the exact nature of the electron-dense deposits. It has been found that the electron density was strictly an osmiumdependent phenomenon, suggesting the presence of a lipid component [19] . The relationship between overstimulation of the alternative pathway of the complement system, whether it is caused by a circulating C3 nephritic factor or factor H deficiency, and DDD, has long been known [19, 21] , although its direct relationship to the nephritis has not yet been elucidated. We had data on the complement profile in eight of our patients with DDD before, and in seven patients after transplantation. All the patients had low C3 in the course of the original disease. After transplantation, a normalization of the complement level was seen in three of them, independent of the severity of the recurrence. These results are similar to the literature data, showing that pre-transplant complement abnormalities can return to normal after transplantation irrespective of the development of a recurrence of the original lesion [5, 22] .
It has been suggested that a recurrence of DDD does not influence graft survival. However, in the published series, 16 out of 101 patients (16%) have lost their graft as a consequence of the recurrence. In our study, recurrence was solely responsible for pro- Figure 2A) . The GBM does not contain electron-dense material. (B) Ribbon like electron-dense deposits in the GBM, with an additional globular deposit in the mesangium. The biopsy is from a patient with C3 deposits both in the capillary loops and in the mesangium (see Figure 2B ). (A) ×15 500; (B) ×12 800. US, urinary space; C, capillary lumen. gression to ESRD in three patients (23%). In the other As mentioned above, three patients lost their graft merely due to recurrent DDD. All three patients had patients with a recurrence, the failure rate was rather high, although it is impossible to judge the impact of heavy proteinuria at the time of biopsy, and the biopsy showed crescents. Six other patients with a recurrence the recurrence on graft failure in these patients. 
